Press Releases and Statements

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today announced the election of three new members to its board of directors during the association’s summer meeting in Washington:

Four leading trade associations representing the dietary supplement industry—the Consumer Healthcare Products Association (CHPA), the American Herbal Products Association (AHPA), the Council for Responsible Nutrition (CRN), and United Natural Products Alliance (UNPA)—today announced their collective support for the re-establishment of the bipartisan, bicameral Congressional Dietary Supplement Caucus in the 119th Congress.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today following the U.S. House of Representatives passing H.R. 2269, the Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act:

(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) today released the below statement following the introduction of H.R.3686, the SAFE Sunscreen Standards Act, bipartisan legislation aimed at modernizing the regulatory process for sunscreen active ingredients in the United States.

2025 data highlights widespread consumer use and value in supplements and clear support for modernizing the regulations overseeing the category.

(WASHINGTON, D.C.) — New research released today by the Consumer Healthcare Products Association’s (CHPA) Health In Hand Foundation shows that after 15 years of public education, more Americans know how to take medicines with acetaminophen safely.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today announced the appointment of M. Scott Furness, Ph.D., to serve as its new Senior Vice President of Regulatory & Scientific Affairs. Dr. Furness comes to CHPA from the U.S. Food and Drug Administration (FDA) where he spent more than 25 years in various leadership roles, most recently as Director of the Division of Product Quality Assessment XVIII at the Center for Drug Evaluation and Research’s (CDER) Office of Pharmaceutical Quality (OPQ), overseeing the scientific review and quality evaluation of the active pharmaceutical ingredient (API) section of regulatory applications and providing strategic guidance on pharmaceutical quality issues. Dr. Furness takes the role previously held by Mike Bailey and officially began his work at CHPA on May 6, 2025. He will serve as a member of CHPA’s Senior Management Team and report to President and CEO Scott Melville.

(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) released the following statement today after submitting comments to the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) regarding its Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients:

(WASHINGTON, DC) – The Consumer Healthcare Products Association’s (CHPA) Health In Hand Foundation today announced its call for nominations for the 2025 U.S. Self-Care Marketing Awards. Winners will be announced at the 10th annual Health In Hand Foundation Gala on Nov. 12 at The Bellevue Hotel in Philadelphia.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the following statement today in response to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. and Food and Drug Administration (FDA) Commissioner Dr. Marty Makary announcing plans to phase out petroleum-based synthetic dyes from the national food supply and replace them with natural ingredients:

(WASHINGTON, D.C.) — Consumer Healthcare Products Association (CHPA) President & CEO Scott Melville today released the following statement in response to the White House’s executive order, “Lowering Drug Prices by Once Again Putting Americans First,” issued this week.